Abstract
Objectives
Atrial fibrillation (AF) is thought to be a progressive arrhythmia, starting with short paroxysmal episodes, until eventually, it becomes permanent. Evidence for this is limited to studies with short follow-up or with minimal cardiac rhythm monitoring. We utilised the continuous rhythm monitoring capabilities of implanted pacemakers to define better the natural history of AF.
Methods
The study included 356 patients with pacemaker devices capable of continuous atrial rhythm monitoring (186 male, mean age (±SD) 79.5 ± 8.9 years). All clinical records, including history/physical examination reports, laboratory results, ECGs and Holter monitoring data were reviewed. Patients were included if AF episodes >30 s were documented. Permanent pacemaker diagnostic data were reviewed at least every 12 months. ACC/AHA/ESC guidelines were used to define AF episodes as paroxysmal, persistent or long-standing persistent/permanent.
Results
Study follow-up period (±SD) was 7.2 ± 3.1 years. Over the study period, 179 of 356 patients (50.3 %) had at least one episode of persistent AF. Of the 356 patients, 314 (88.2 %) had paroxysmal AF and 42 (11.8 %) had persistent AF at the time of diagnosis. The predominant AF subtype, at latest follow-up, was paroxysmal for 192 patients (53.9 %), persistent for 77 (21.6 %) and long-standing persistent/permanent for 87 (24.4 %). Univariable predictors of progression to persistent AF were (1) male gender, (2) increasing left atrial diameter (LAD), (3) reduced atrial pacing (AP) and (4) increasing ventricular pacing.
Conclusions
Although many patients with AF will have persistent episodes, long-term continuous pacemaker follow-up demonstrates that the majority will have a paroxysmal, as opposed to persistent, form of the arrhythmia.
Similar content being viewed by others
References
Bagai, J., & Avitall, B. (2001). Atrial fibrillation. Current Treatment Options in Cardiovascular Medicine, 3(4), 261–276.
Camm, A. J., Kirchhof, P., Lip, G. Y., et al. (2010). Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC). European Heart Journal, 29.
Wijffels, M. C., Kirchhof, C. J., Dorland, R., et al. (1995). Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation, 92(7), 1954–1968.
Page, R. L., Wilkinson, W. E., Clair, W. K., et al. (1994). Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. Circulation, 89(1), 224–227.
Silberbauer, J., Veasey, R. A., Cheek, E., et al. (2009). Electrophysiological characteristics associated with symptoms in pacemaker patients with paroxysmal atrial fibrillation. Journal of Interventional Cardiac Electrophysiology, 26(1), 31–40.
Chugh, S. S., Blackshear, J. L., Shen, W. K., et al. (2001). Epidemiology and natural history of atrial fibrillation: clinical implications. Journal of the American College of Cardiology, 37(2), 371–378.
Carlioz, O., Perrier, E., Thomas, O., et al. (2000). Accuracy of atrial tachyarrhythmia monitoring in a Selection device: correlation with an external Holter recording. Europace, 1(Suppl D), 9–10.
Israel, C. W. (2002). Analysis of mode switching algorithms in dual chamber pacemakers. Pacing and Clinical Electrophysiology, 25(3), 380–393.
Jarwe, M., Klug, D., Marquie, C., et al. (2001). Description of an atrial tachyarrhythmia patient population with a dual chamber pacemaker. Europace, 2(Abstract Suppl), A20.
Purerfellner, H., Gillis, A. M., Holbrook, R., et al. (2004). Accuracy of atrial tachyarrhythmia detection in implantable devices with arrhythmia therapies. Pacing and Clinical Electrophysiology, 27(7), 983–992.
Silberbauer, J., Arya, A., Veasey, R. A., et al. (2010). The effect of bipole tip-to-ring distance in atrial electrodes upon atrial tachyarrhythmia sensing capability in modern dual-chamber pacemakers. Pacing and Clinical Electrophysiology, 33(1), 85–93.
Veasey, R. A., Arya, A., Freemantle, N., et al. (2010). The usefulness of minimal ventricular pacing and preventive AF algorithms in the treatment of PAF: the 'MinVPace' study. J Intervent Cardiac Electrophysiol, 28(1), 51–57.
Fuster, V., Ryden, L. E., Cannom, D. S., et al. (2006). ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace, 8(9), 651–745.
Al-Khatib, S. M., Wilkinson, W. E., Sanders, L. L., et al. (2000). Observations on the transition from intermittent to permanent atrial fibrillation. American Heart Journal, 140(1), 142–145.
Jahangir, A., Lee, V., Friedman, P. A., et al. (2007). Long-term progression and outcomes with aging in patients with lone atrial fibrillation: a 30-year follow-up study. Circulation, 115(24), 3050–3056.
Kerr, C. R., Humphries, K. H., Talajic, M., et al. (2005). Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: results from the Canadian Registry of Atrial Fibrillation. American Heart Journal, 149(3), 489–496.
Nieuwlaat, R., Prins, M. H., Le Heuzey, J. Y., et al. (2008). Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on atrial fibrillation. European Heart Journal, 29(9), 1181–1189.
Ruigomez, A., Johansson, S., Wallander, M. A., et al. (2005). Predictors and prognosis of paroxysmal atrial fibrillation in general practice in the UK. BMC Cardiovascular Disorders, 5, 20.
Saksena, S., Hettrick, D. A., Koehler, J. L., et al. (2007). Progression of paroxysmal atrial fibrillation to persistent atrial fibrillation in patients with bradyarrhythmias. American Heart Journal, 154(5), 884–892.
Nagarakanti, R., Saksena, S., Hettrick, D., et al. (2011). Progression of new onset to established persistent atrial fibrillation: an implantable device-based analysis with implications for clinical classification of persistent atrial fibrillation. Journal of Interventional Cardiac Electrophysiology, 32(1), 7–15.
Sweeney, M. O., Bank, A. J., Nsah, E., et al. (2007). Minimizing ventricular pacing to reduce atrial fibrillation in sinus-node disease. New England Journal of Medicine, 357(10), 1000–1008.
Veasey, R. A., Arya, A., Silberbauer, J., et al. (2011). The relationship between right ventricular pacing and atrial fibrillation burden and disease progression in patients with paroxysmal atrial fibrillation: the long-MinVPACE study. Europace, 13(6), 815–820.
Benjamin, E. J., Levy, D., Vaziri, S. M., et al. (1994). Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA, 271(11), 840–844.
Buch, P., Friberg, J., Scharling, H., et al. (2003). Reduced lung function and risk of atrial fibrillation in the Copenhagen City Heart Study. European Respiratory Journal, 21(6), 1012–1016.
Healey, J. S., & Connolly, S. J. (2003). Atrial fibrillation: hypertension as a causative agent, risk factor for complications, and potential therapeutic target. American Journal of Cardiology, 91(10A), 9G–14G.
Humphries, K. H., Kerr, C. R., Connolly, S. J., et al. (2001). New-onset atrial fibrillation: sex differences in presentation, treatment, and outcome. Circulation, 103(19), 2365–2370.
Benjamin, E. J., Wolf, P. A., D'Agostino, R. B., et al. (1998). Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation, 98(10), 946–952.
Stewart, S., Hart, C. L., Hole, D. J., et al. (2002). A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. American Journal of Medicine, 113(5), 359–364.
Kopecky, S. L., Gersh, B. J., McGoon, M. D., et al. (1987). The natural history of lone atrial fibrillation. A population-based study over three decades. New England Journal of Medicine, 317(11), 669–674.
Kopecky, S. L., Gersh, B. J., McGoon, M. D., et al. (1999). Lone atrial fibrillation in elderly persons: a marker for cardiovascular risk. Archives of Internal Medicine, 159(10), 1118–1122.
Glotzer, T. V., Hellkamp, A. S., Zimmerman, J., et al. (2003). Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST). Circulation, 107(12), 1614–1619.
Glotzer, T. V., Daoud, E. G., Wyse, D. G., et al. (2009). The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study. Circulation. Arrhythmia and Electrophysiology, 2(5), 474–480.
Healey, J. S., Connolly, S. J., Gold, M. R., et al. (2012). Subclinical atrial fibrillation and the risk of stroke. New England Journal of Medicine, 366(2), 120–129.
Author contributions
RA Veasey did the conception and design, analysis and interpretation of data and drafted of the manuscript. C Sugihara revised the manuscript critically for important intellectual content. K Sandhu revised the manuscript critically for important intellectual content. G Dhillon revised the manuscript critically for important intellectual content. N Freemantle did the analysis and interpretation of data and revised the manuscript critically for important intellectual content. SS Furniss revised the manuscript critically for important intellectual content. N Sulke revised the manuscript critically for important intellectual content and final approval of the manuscript submitted.
Funding
None
Competing interests
The authors declare that they have no competing interests.
Conflict of interest
The authors state no interests which might be perceived as posing a conflict or bias.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Veasey, R.A., Sugihara, C., Sandhu, K. et al. The natural history of atrial fibrillation in patients with permanent pacemakers: is atrial fibrillation a progressive disease?. J Interv Card Electrophysiol 44, 23–30 (2015). https://doi.org/10.1007/s10840-015-0029-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10840-015-0029-x